Edwards Lifesciences (EW)

Company Profile

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. Edwards Lifesciences is driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.

Company profile

Ticker

Exchange

NYSE

Website

www.edwards.com

CEO

Michael Mussallem

Incorporated

Delaware

Location

California

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Avanos Medical • Invacare • MSA Safety • Align Technology • Surgalign • RTI Surgical ...

Former names

CVG CONTROLLED INC

SEC CIK

0001099800

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Edwards Lifesciences LLC • Edwards Lifesciences (U.S.) Inc. • Edwards Lifesciences (Japan) Limited • Edwards Lifesciences Holding B.V. ...

IRS number

364316614

EW stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$95.00

Low target

$73.00

High target

$110.00

Latest filings (excl ownership)

View all

8-K

Edwards Lifesciences Announces $750 Million Accelerated Share Repurchase

28 Oct 22

Edwards Lifesciences Reports Third Quarter Results

29 Jul 22

Edwards Lifesciences Reports Second Quarter Results

28 Jul 22

S-3ASR

Automatic shelf registration

21 Jul 22

8-K

Entry into a Material Definitive Agreement

21 Jul 22

Conflict minerals disclosure

31 May 22

8-K

Submission of Matters to a Vote of Security Holders

28 Apr 22

Transcripts

View all

Earnings call transcript

2022 Q3

28 Oct 22

Earnings call transcript

2022 Q2

29 Jul 22

Earnings call transcript

2022 Q1

27 Apr 22

Earnings call transcript

2021 Q4

27 Jan 22

Earnings call transcript

2021 Q3

28 Oct 21

Earnings call transcript

2021 Q2

30 Jul 21

Earnings call transcript

2021 Q1

21 Apr 21

Earnings call transcript

2020 Q4

28 Jan 21

Earnings call transcript

2020 Q3

22 Oct 20

Earnings call transcript

2020 Q2

23 Jul 20

Latest ownership filings

View all

Notice of proposed sale of securities

7 Oct 22

MICHAEL A MUSSALLEM

22 Sep 22

Financial summary

Financial statements Chart EW financial data

Quarter (USD)	Sep 22	Jun 22	Mar 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	1.25 bn	1.25 bn	1.25 bn	1.25 bn	1.25 bn	1.25 bn
Cash burn (monthly)	(no burn)	22.35 mm	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	n/a	47.78 mm	n/a	n/a	n/a	n/a
Cash remaining	n/a	1.20 bn	n/a	n/a	n/a	n/a
Runway (months of cash)	n/a	53.9	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2022

EW institutional ownership history Ownership history

75.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	1174	1218	-3.6%
Opened positions	101	113	-10.6%
Closed positions	145	152	-4.6%
Increased positions	427	434	-1.6%
Reduced positions	434	453	-4.2%

13F shares	Current	Prev Q	Change
Total value	38.70 bn	47.31 bn	-18.2%
Total shares	468.05 mm	496.38 mm	-5.7%
Total puts	1.07 mm	1.19 mm	-10.4%
Total calls	1.84 mm	1.45 mm	+27.0%
Total put/call ratio	0.6	0.8	-29.4%

Largest owners	Shares	Value	Change
BLK Blackrock	52.40 mm	$4.33 bn	-6.0%
Vanguard	50.91 mm	$4.21 bn	+1.2%
Capital International Investors	22.70 mm	$1.88 bn	+1.3%
BK Bank Of New York Mellon	20.27 mm	$1.67 bn	-6.3%
Alliancebernstein	17.16 mm	$1.42 bn	+4.9%
Wellington Management	14.65 mm	$1.21 bn	+3.3%
Brown Advisory	14.23 mm	$1.18 bn	+3.1%
Geode Capital Management	11.93 mm	$984.63 mm	+1.7%
Sands Capital Management	10.41 mm	$859.84 mm	-11.2%
Fisher Asset Management	7.54 mm	$622.93 mm	+2.8%

Largest transactions	Shares	Bought/sold	Change
STT State Street	0.00	-26.90 mm	EXIT
BLK Blackrock	52.40 mm	-3.34 mm	-6.0%
Millennium Management	2.31 mm	+2.26 mm	+5018.3%
FMR	6.62 mm	-2.24 mm	-25.3%
Marshall Wace	3.51 mm	+2.20 mm	+167.5%
Schroder Investment Management	792.05 k	-1.95 mm	-71.1%
BK Bank Of New York Mellon	20.27 mm	-1.36 mm	-6.3%
Sands Capital Management	10.41 mm	-1.31 mm	-11.2%
Lord, Abbett & Co.	73.02 k	-1.30 mm	-94.7%
Amundi	6.44 mm	+1.15 mm	+21.9%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

EW insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
15 Nov 22	Chopra Daveen	Common Stock	Sell	Dispose S	No	Yes	74.18	4,000	296.72 k	18,911
15 Nov 22	Chopra Daveen	Common Stock	Option exercise	Acquire M	No	Yes	45.2767	4,000	181.11 k	22,911
15 Nov 22	Chopra Daveen	Employee Stock Option (Right to Acquire) Common Stock	Option exercise	Dispose M	No	No	45.2767	4,000	181.11 k	16,435
14 Nov 22	Mussallem Michael A	Common Stock	Gift	Acquire G	Yes	No	0	9,500	0.00	3,463,517
14 Nov 22	Mussallem Michael A	Common Stock	Sell	Dispose S	No	Yes	73.94	15,575	1.15 mm	157,352.82
14 Nov 22	Mussallem Michael A	Common Stock	Gift	Dispose G	No	No	0	9,500	0.00	172,927.82
14 Nov 22	Mussallem Michael A	Common Stock	Sell	Dispose S	No	Yes	74.86	4,100	306.93 k	182,427.82
14 Nov 22	Mussallem Michael A	Common Stock	Sell	Dispose S	No	Yes	75.47	200	15.09 k	186,527.82
14 Nov 22	Mussallem Michael A	Common Stock	Option exercise	Acquire M	No	Yes	35.1967	29,375	1.03 mm	186,727.82
14 Nov 22	Mussallem Michael A	Employee Stock Option (Right to Acquire) Common Stock	Option exercise	Dispose M	No	No	35.1967	29,375	1.03 mm	176,250